Evaluation of antimicrobial and antiplatelet aggregation effects of Solidago chilensis Meyen

Liz Rafael, Neiva Teresinha, J. C. Moritz, I. G. Maria, M. Dalmarco Eduardo, S. Fröde Tânia


Solidago species have been used in popular medicine for the treatment of several inflammatory conditions. The aim of this study is to evaluate both the antimicrobial and antiplatelet effects of Solidago chilensis Meyen rhizome aqueous extract and its derived fractions using in-vitro models. The antimicrobial analysis was performed against Staphylococcus aureus (ATCC 25922), Escherichia coli (ATCC 25923) and Pseudomonas aeruginosa (ATCC 27853). The broth microdilution method was used to determine the minimal inhibitory concentration (MIC). The measurement of platelet aggregation was determined by turbidimetric methodology. Significant differences
were determined by analysis of variance (ANOVA), Dunnett’s or Student’s t tests. Values of P < 0.05 were considered significant. Theaqueous extract and its derived fractions prevented the growth of all the three tested microbial species. Furthermore, these extracts also significantly inhibited platelet aggregation (% of inhibition: AE: 45.0±4.0%, BuOH: 29.6±3.1% to 13.8±2.6%, and AR: 41.7±4.2%). Solidago chilensis Meyen rhizomes demonstrated important antimicrobial and antiplatelet aggregation activities, which may underlie their beneficial effect on bacterial infection and atherothrombotic diseases.
Key words: Antimicrobial effect, antiplatelet activity, Solidago chilensis Meyen

Full Text:



Melzig MF. Goldenrod: A classical exponent in the urological

phytotherapy. Wien Med Wochenschr 2004;154:523-7.

Morel AF, Dias GO, Porto C, Simionatto E, Stuker CZ,

Dalcol II. Antimicrobial activity of extractives of Solidago

microglossa. Fitoterapia 2006;77:453-5.

Sampson JH, Phillipson JD, Bowery NG, O’neill MJ, Houston JG,

Lewis JA. Ethnomedicinally selected plants as sources of potential

analgesic compounds: Indication of in-vitro biological activity in

receptor binding assays. Phytother Res 2000;14:24-9.

Gross SC, Goodarzi G, Watabe M, Bandyopadhyay S, Pai SK,

Watabe K. Antineoplasic activity of Solidago virgaurea on prostatic

tumor cells in an SCID mouse model. Nutr Cancer 2002;43:76-81.

McCune LM, Johns T. Antioxidant activity in medicinal plants

associated with the symptoms of diabetes mellitus used by

the indigenous peoples of the North American boreal forest.

J Ethnopharmacol 2002;82:197-205.

Lorenzi H, Matos FJ. Plantas Medicinais no Brasil - Nativas e

exóticas, Instituto Plantarum de Estudos da Flora. São Paulo,

Brazil: 2002.

Brazilian Pharmacopoeia, Companhia Editora Nacional. São

Paulo, Brazil: 1929.

Batyuk VS, Kovaleva SN. Flavonoids of Solidago canadensis and

Solidago virgaurea. Khimiia Prirodnykh Soedinenii 1985;21:566-7.

Kim DW, Chi YS, Son KH, Chang HW, Kim JS, Kang SS, et al.

Effects of sophoraflavanone G, a prenylated flavonoid from

Sophora flavescens, on cyclooxygenase-2 and in-vivo inflammatory

response. Arch Pharm Res 2002;25:329-35.

Mbaveng AT, Ngameni B, Kuete V, Simo IK, Ambassa P, Roy R,

et al. Antimicrobial activity of the crude extracts and five flavonoids

from the twigs of Dorstenia barteri (Moraceae). J Ethnopharmacol


Koleckar V, Brojerova E, Rehakova Z, Kubikova K, Cervenka F,

Kuca K, et al. In-vitro antiplatelet activity of flavonoids from Leuzea

carthamoides. Drug Chem Toxicol 2008;31:27-35.

Wu B, Takahashi T, Kashiwagi T, Tebayashi S, Kim CS. New

flavonoid glycosides from the leaves of Solidago altissima. Chem

Pharm Bull (Tokyo) 2007;55:815-6.

Apáti P, Houghton PJ, Kéry A. HPLC investigation of antioxidant

components in Solidago herba. Acta Pharm Hung 2004;74:223-31.

Gutierrez AB, Oberti JC, Juliani HR. Constituents of Solidago

chilensis (Compositae). Anales. Asociación de Quimica del

Argentina 1981;69:27-31.

Steliopoulos P, Wüst M, Adam KP, Mosandl A. Biosynthesis of the

sesquiterpene germacrene D in Solidago canadensis: 13C and (2) H

labeling studies. Phytochemistry 2002;60:13-20.

Bradette-Hébert ME, Legault J, Lavoie S, Pichette A. A new labdane

diterpene from the flowers of Solidago canadensis. Chem Pharm

Bull 2008;56:82-4.

Apáti P, Houghton PJ, Kite G, Steventon GB, Kéry A. In-vitro effect

of flavonoids from Solidago canadensis extract on glutathione

S-transferase. J Pharm Pharmacol 2006;58:251-6.

Bader G, Wray V, Hiller K. The main saponins from the aerial

parts and the roots of Solidago virgaurea subsp. virgaurea. Planta

Med 1995;61:158-61.

Zeng FR, Yin SM, Xie SF, Nie DN, Ma LP, Feng JH, et al. Effects of

A-1-1 on the aggregation and Ca2+ influx of platelets. Zhonghua

Xue Ye Xue Za Zhi 2004;25:544-7.

Almeida AA, Farah A, Silva DA, Nunan EA, Glória MB.

Antibacterial activity of coffee extracts and selected coffee

chemical compounds against enterobacteria. J Agric Food Chem


Avato P, Bucci R, Tava A, Vitali C, Rosato A, Bialy Z, et al.

Antimicrobial activity of saponins from Medicago sp.: Structureactivity

relationship. Phytother Res 2006;20:454-7.

Thisoda P, Rangkadilok N, Pholphana N, Worasuttayangkurn L,

Ruchirawat S, Satayavivad J. Inhibitory effect of Andrographis

paniculata extract and its active diterpenoids on platelet

aggregation. Eur J Pharmacol 2006;553:39-45.

Hsu HC, Yang WC, Tsai WJ, Chen CC, Huang HY, Tsai YC.

Alpha-bulnesene: A novel PAF receptor antagonist isolated

from Pogostemon cablin. Biochem Biophys Res Commun


Kuzma Ł, Rózalski M, Walencka E, Rózalska B, Wysokińska H.

Antimicrobial activity of diterpenoids from hairy roots of

Salvia sclarea L.: Salvipisone as a potential anti-biofilm agent

active against antibiotic resistant Staphylococci. Phytomedicine


Lee JJ, Jin YR, Lee JH, Yu JY, Han XH, Oh KW, et al. Antiplatelet

activity of carnosic acid: A phenolic diterpene from Rosmarinus

officinalis. Planta Med 2007;73:121-7.

Satake T, Kamiya K, An Y, Oishi Nee Taka T, Yamamoto J. The

anti-thrombotic active constituents from Centella asiatica. Biol

Pharm Bull 2007;30:935-40.

Djeddi S, Karioti A, Sokovic M, Koukoulitsa C, Skaltsa H. A novel

sesquiterpene lactone from Centaurea pullata: Structure elucidation,

antimicrobial activity, and prediction of pharmacokinetic

properties. Bioorg Med Chem 2008;16:3725-31.

Natella F, Nardini M, Belelli F, Pignatelli P, Di Santo S, Ghiselli A,

et al. Effect of coffee drinking on platelets: inhibition of aggregation

and phenols incorporation. Br J Nutr 2008;28:1-7.

Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RA.

Manual of Clinical Microbiology. 8th ed. Washington, DC: ASM

Press; 2003.

National Committee for Clinical Laboratory Standards (CLSI),

Performance standards for antimicrobial susceptibility testing,

Fifteenth Informational Supplement M100-S15, Wayne, PA:

Drummond AJ, Waigh RD. Recent Research Developments in

Phytochemistry 2000;4:143-52.

Born GV, Cross MJ. Aggregation of blood platelets. J Physiol


Rossi A, Longo R, Russo A, Borrelli F, Sautebin L. The role of the

phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung

cyclooxygenase activity by propolis. Fitoterapia 2002;73:30-7.

Campos FM, Couto JA, Hogg TA. Influence of phenolic acids on

growth and inactivation of Oenococcus oeni and Lactobacillus

hilgardii. J Appl Microbiol 2003;94:167-74.

Park JB. Caffedymine from cocoa has COX inhibitory activity

suppressing the expression of a platelet activation marker,

P-selectin. J Agric Food Chem 2007;55:2171-5.

DOI: http://dx.doi.org/10.22377/ijgp.v3i1.53


  • There are currently no refbacks.